chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: Facial numbness; Severe headaches; Shooting pain through head/skull; Blurred vision at times; Body aches; Fever; Chills; Sore arm; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FE3592) via an unspecified route of administration in the left arm on 14Sep2021 at 11:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included pacemaker for sick sinus syndrome, hypothyroidism and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included thyroid (ARMOUR THYROID), pantoprazole (MANUFACTURER UNKNOWN) and medroxyprogesterone (MANUFACTURER UNKNOWN); all for unknown indication from unknown date and unknown if ongoing. The patient previously received technetium tc 99m imidodiphosphate (TECHNETIUM 99M IDP) and propylthiouracil (PROPYLTHIURACIL); both for unknown indication on unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3182) via an unspecified route of administration in the left arm on 24Aug2021 at 12:15 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. On 13Sep2021, the patient underwent COVID-19 test via nasal swab and the result was negative. On 14Sep2021 at 13:00 the patient experienced facial numbness, severe headaches, shooting pain through head/skull, blurred vision at times, body aches, fever, chills, sore arm, and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On 15Sep2021, the patient underwent COVID-19 test via nasal swab and the result was negative. On 17Sep2021, the patient underwent COVID-19 test via nasal swab and the result was negative. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events facial numbness, severe headaches, shooting pain through head/skull, blurred vision at times, body aches, fever, chills, sore arm, fatigue was not resolved at the time of this report.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Fatigue, Headache, Hypoaesthesia, Pain
Clinical narrative: Facial numbness; Severe headaches; Shooting pain through head/skull; Blurred vision at times; Body aches; Fever; Chills; Sore arm; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FE3592) via an unspecified route of administration in the left arm on 14Sep2021 at 11:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included pacemaker for sick sinus syndrome, hypothyroidism and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included thyroid (ARMOUR THYROID), pantoprazole (MANUFACTURER UNKNOWN) and medroxyprogesterone (MANUFACTURER UNKNOWN); all for unknown indication from unknown date and unknown if ongoing. The patient previously received technetium tc 99m imidodiphosphate (TECHNETIUM 99M IDP) and propylthiouracil (PROPYLTHIURACIL); both for unknown indication on unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3182) via an unspecified route of administration in the left arm on 24Aug2021 at 12:15 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. On 13Sep2021, the patient underwent COVID-19 test via nasal swab and the result was negative. On 14Sep2021 at 13:00 the patient experienced facial numbness, severe headaches, shooting pain through head/skull, blurred vision at times, body aches, fever, chills, sore arm, and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On 15Sep2021, the patient underwent COVID-19 test via nasal swab and the result was negative. On 17Sep2021, the patient underwent COVID-19 test via nasal swab and the result was negative. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events facial numbness, severe headaches, shooting pain through head/skull, blurred vision at times, body aches, fever, chills, sore arm, fatigue was not resolved at the time of this report.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain in extremity, Pyrexia, SARS-CoV-2 test, Vision blurred
Clinical narrative: Facial numbness; Severe headaches; Shooting pain through head/skull; Blurred vision at times; Body aches; Fever; Chills; Sore arm; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FE3592) via an unspecified route of administration in the left arm on 14Sep2021 at 11:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included pacemaker for sick sinus syndrome, hypothyroidism and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included thyroid (ARMOUR THYROID), pantoprazole (MANUFACTURER UNKNOWN) and medroxyprogesterone (MANUFACTURER UNKNOWN); all for unknown indication from unknown date and unknown if ongoing. The patient previously received technetium tc 99m imidodiphosphate (TECHNETIUM 99M IDP) and propylthiouracil (PROPYLTHIURACIL); both for unknown indication on unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3182) via an unspecified route of administration in the left arm on 24Aug2021 at 12:15 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. On 13Sep2021, the patient underwent COVID-19 test via nasal swab and the result was negative. On 14Sep2021 at 13:00 the patient experienced facial numbness, severe headaches, shooting pain through head/skull, blurred vision at times, body aches, fever, chills, sore arm, and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On 15Sep2021, the patient underwent COVID-19 test via nasal swab and the result was negative. On 17Sep2021, the patient underwent COVID-19 test via nasal swab and the result was negative. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events facial numbness, severe headaches, shooting pain through head/skull, blurred vision at times, body aches, fever, chills, sore arm, fatigue was not resolved at the time of this report.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Chest pain, Dizziness, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: Shingle-like symptoms; Dizziness; Stomach cramping; Neck stiffness; Chest pains; This is a spontaneous report from a contactable pharmacist, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0202) via an unspecified route of administration in left arm on 19Aug2021 at 14:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as not available. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received azithromycin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and experienced allergy to antibiotic. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 19Aug2021 at 16:00, the patient experienced shingle-like symptoms, dizziness, stomach cramping, neck stiffness and chest pains. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shingle-like symptoms, dizziness, stomach cramping, neck stiffness and chest pains was not resolved at the time of report.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Restless legs syndrome
Clinical narrative: Shingle-like symptoms; Dizziness; Stomach cramping; Neck stiffness; Chest pains; This is a spontaneous report from a contactable pharmacist, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0202) via an unspecified route of administration in left arm on 19Aug2021 at 14:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as not available. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received azithromycin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and experienced allergy to antibiotic. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 19Aug2021 at 16:00, the patient experienced shingle-like symptoms, dizziness, stomach cramping, neck stiffness and chest pains. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shingle-like symptoms, dizziness, stomach cramping, neck stiffness and chest pains was not resolved at the time of report.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Chest pain, Dizziness, Herpes zoster, Musculoskeletal stiffness
Clinical narrative: Shingle-like symptoms; Dizziness; Stomach cramping; Neck stiffness; Chest pains; This is a spontaneous report from a contactable pharmacist, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0202) via an unspecified route of administration in left arm on 19Aug2021 at 14:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as not available. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received azithromycin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and experienced allergy to antibiotic. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 19Aug2021 at 16:00, the patient experienced shingle-like symptoms, dizziness, stomach cramping, neck stiffness and chest pains. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shingle-like symptoms, dizziness, stomach cramping, neck stiffness and chest pains was not resolved at the time of report.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Swelling face
Clinical narrative: 2nd dose administration date=04Feb2021, 1st dose administration date=25Feb2021; I experienced a headache; then a few hours later my face swelled up; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an 22 age received bnt162b2 (BNT162B2; solution for injection; Lot number and expiry date was not reported), dose 1 solution for injection via an unspecified route of administration at arm Right on 25Feb2021 07:00 (at the age of 22-years-old) as a single for covid-19 immunisation. The patient medical history was not reported. Patient has no allergies. No covid prior to vaccination, no covid tested post vaccination. No other vaccine in four weeks, and no other medications in two weeks The patient's concomitant medications were not reported. The patient experienced 2nd dose administration date 04feb2021, 1st dose administration date 25feb2021 inappropriate schedule of product administration on 25Feb2021 08:00, she experienced a headache on 25Feb2021 08:00, then a few hours later my face swelled up on 25Feb2021 08:00. Patient received a steroids shot. No treatment received for AE. Outcome of the events were recovering, and other event were unknown.   No follow-up attempts are possible. No further information is expected.   ; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021244696 similar report from same reporter
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Inappropriate schedule of product administration, Swelling face
Clinical narrative: 2nd dose administration date=04Feb2021, 1st dose administration date=25Feb2021; I experienced a headache; then a few hours later my face swelled up; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an 22 age received bnt162b2 (BNT162B2; solution for injection; Lot number and expiry date was not reported), dose 1 solution for injection via an unspecified route of administration at arm Right on 25Feb2021 07:00 (at the age of 22-years-old) as a single for covid-19 immunisation. The patient medical history was not reported. Patient has no allergies. No covid prior to vaccination, no covid tested post vaccination. No other vaccine in four weeks, and no other medications in two weeks The patient's concomitant medications were not reported. The patient experienced 2nd dose administration date 04feb2021, 1st dose administration date 25feb2021 inappropriate schedule of product administration on 25Feb2021 08:00, she experienced a headache on 25Feb2021 08:00, then a few hours later my face swelled up on 25Feb2021 08:00. Patient received a steroids shot. No treatment received for AE. Outcome of the events were recovering, and other event were unknown.   No follow-up attempts are possible. No further information is expected.   ; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021244696 similar report from same reporter
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: ADMINISTERED EXPIRED VACCINE; This spontaneous report received from a health care professional concerned a 47 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, expiry: 19-SEP-2021) dose was not reported, administered on 21-SEP-2021 10:00 for prophylactic vaccination. No concomitant medications were reported.  On 21-SEP-2021, the patient experienced administered expired vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administered expired vaccine was not reported. This report was non-serious.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Adenovirus test, Antibody test, Arachnoid cyst, Biopsy bone marrow abnormal
Clinical narrative: 64 year old patient with history of ASH/NASH cirrhosis c/b encephalopathy, ascites (multiple LVPs in past), edema and esophageal varices (no bleeds) who had an umbilical hernia repair in 8/2020, CKD (stage 3), who underwent liver transplant on 5/12/2021. Patient reported fatigue and malaise since the COVID vaccination on 8/26/2021 (Pfizer) and was presented to the hospital on 9/8/2021 with persistently high fevers and altered mental status and given broad spectrum antibiotics without being able to localize the source of infection. Lumbar puncture was normal and a bone marrow biopsy was reviewed with the hematology department who diagnosed the patient with HLH. Patient was neutropenic when he came in with a WBC of 0.8 which recovered to 2.4 after receiving Zarxio from 9/8-9/12. 9/16 Patient was treated with IVIG (60g/day) x 3 days, methylprednisolone 3 mg/kg x 3 days, then 2 mg/kg x 3 days, then 1 mg/kg for 4 days. Remains on vasopressors including norepinephrine, vasopressin, and phenylephrine and is being treated with meropenem with no localized source of infection. Patient is currently intubated.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blast cells, Blood beta-D-glucan normal, Blood creatinine increased, Blood smear test normal, Bone lesion
Clinical narrative: 64 year old patient with history of ASH/NASH cirrhosis c/b encephalopathy, ascites (multiple LVPs in past), edema and esophageal varices (no bleeds) who had an umbilical hernia repair in 8/2020, CKD (stage 3), who underwent liver transplant on 5/12/2021. Patient reported fatigue and malaise since the COVID vaccination on 8/26/2021 (Pfizer) and was presented to the hospital on 9/8/2021 with persistently high fevers and altered mental status and given broad spectrum antibiotics without being able to localize the source of infection. Lumbar puncture was normal and a bone marrow biopsy was reviewed with the hematology department who diagnosed the patient with HLH. Patient was neutropenic when he came in with a WBC of 0.8 which recovered to 2.4 after receiving Zarxio from 9/8-9/12. 9/16 Patient was treated with IVIG (60g/day) x 3 days, methylprednisolone 3 mg/kg x 3 days, then 2 mg/kg x 3 days, then 1 mg/kg for 4 days. Remains on vasopressors including norepinephrine, vasopressin, and phenylephrine and is being treated with meropenem with no localized source of infection. Patient is currently intubated.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Bone marrow failure, CSF immunoglobulin, CSF immunoglobulin G index, CSF white blood cell count negative, Computerised tomogram abdomen normal
Clinical narrative: 64 year old patient with history of ASH/NASH cirrhosis c/b encephalopathy, ascites (multiple LVPs in past), edema and esophageal varices (no bleeds) who had an umbilical hernia repair in 8/2020, CKD (stage 3), who underwent liver transplant on 5/12/2021. Patient reported fatigue and malaise since the COVID vaccination on 8/26/2021 (Pfizer) and was presented to the hospital on 9/8/2021 with persistently high fevers and altered mental status and given broad spectrum antibiotics without being able to localize the source of infection. Lumbar puncture was normal and a bone marrow biopsy was reviewed with the hematology department who diagnosed the patient with HLH. Patient was neutropenic when he came in with a WBC of 0.8 which recovered to 2.4 after receiving Zarxio from 9/8-9/12. 9/16 Patient was treated with IVIG (60g/day) x 3 days, methylprednisolone 3 mg/kg x 3 days, then 2 mg/kg x 3 days, then 1 mg/kg for 4 days. Remains on vasopressors including norepinephrine, vasopressin, and phenylephrine and is being treated with meropenem with no localized source of infection. Patient is currently intubated.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cryptococcus test, Cytomegalovirus test negative, Effusion, Encephalopathy, Epstein-Barr virus test negative
Clinical narrative: 64 year old patient with history of ASH/NASH cirrhosis c/b encephalopathy, ascites (multiple LVPs in past), edema and esophageal varices (no bleeds) who had an umbilical hernia repair in 8/2020, CKD (stage 3), who underwent liver transplant on 5/12/2021. Patient reported fatigue and malaise since the COVID vaccination on 8/26/2021 (Pfizer) and was presented to the hospital on 9/8/2021 with persistently high fevers and altered mental status and given broad spectrum antibiotics without being able to localize the source of infection. Lumbar puncture was normal and a bone marrow biopsy was reviewed with the hematology department who diagnosed the patient with HLH. Patient was neutropenic when he came in with a WBC of 0.8 which recovered to 2.4 after receiving Zarxio from 9/8-9/12. 9/16 Patient was treated with IVIG (60g/day) x 3 days, methylprednisolone 3 mg/kg x 3 days, then 2 mg/kg x 3 days, then 1 mg/kg for 4 days. Remains on vasopressors including norepinephrine, vasopressin, and phenylephrine and is being treated with meropenem with no localized source of infection. Patient is currently intubated.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Flow cytometry, Fungal test negative, Granulocyte percentage, Haemophagocytic lymphohistiocytosis
Clinical narrative: 64 year old patient with history of ASH/NASH cirrhosis c/b encephalopathy, ascites (multiple LVPs in past), edema and esophageal varices (no bleeds) who had an umbilical hernia repair in 8/2020, CKD (stage 3), who underwent liver transplant on 5/12/2021. Patient reported fatigue and malaise since the COVID vaccination on 8/26/2021 (Pfizer) and was presented to the hospital on 9/8/2021 with persistently high fevers and altered mental status and given broad spectrum antibiotics without being able to localize the source of infection. Lumbar puncture was normal and a bone marrow biopsy was reviewed with the hematology department who diagnosed the patient with HLH. Patient was neutropenic when he came in with a WBC of 0.8 which recovered to 2.4 after receiving Zarxio from 9/8-9/12. 9/16 Patient was treated with IVIG (60g/day) x 3 days, methylprednisolone 3 mg/kg x 3 days, then 2 mg/kg x 3 days, then 1 mg/kg for 4 days. Remains on vasopressors including norepinephrine, vasopressin, and phenylephrine and is being treated with meropenem with no localized source of infection. Patient is currently intubated.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hepatic enzyme increased, Human herpes virus 6 serology negative, Human herpes virus 8 test, Hyperplasia, Immunoglobulin therapy
Clinical narrative: 64 year old patient with history of ASH/NASH cirrhosis c/b encephalopathy, ascites (multiple LVPs in past), edema and esophageal varices (no bleeds) who had an umbilical hernia repair in 8/2020, CKD (stage 3), who underwent liver transplant on 5/12/2021. Patient reported fatigue and malaise since the COVID vaccination on 8/26/2021 (Pfizer) and was presented to the hospital on 9/8/2021 with persistently high fevers and altered mental status and given broad spectrum antibiotics without being able to localize the source of infection. Lumbar puncture was normal and a bone marrow biopsy was reviewed with the hematology department who diagnosed the patient with HLH. Patient was neutropenic when he came in with a WBC of 0.8 which recovered to 2.4 after receiving Zarxio from 9/8-9/12. 9/16 Patient was treated with IVIG (60g/day) x 3 days, methylprednisolone 3 mg/kg x 3 days, then 2 mg/kg x 3 days, then 1 mg/kg for 4 days. Remains on vasopressors including norepinephrine, vasopressin, and phenylephrine and is being treated with meropenem with no localized source of infection. Patient is currently intubated.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Interleukin-2 receptor assay, Lethargy, Liver function test increased, Lumbar puncture normal, Lymphocyte percentage decreased
Clinical narrative: 64 year old patient with history of ASH/NASH cirrhosis c/b encephalopathy, ascites (multiple LVPs in past), edema and esophageal varices (no bleeds) who had an umbilical hernia repair in 8/2020, CKD (stage 3), who underwent liver transplant on 5/12/2021. Patient reported fatigue and malaise since the COVID vaccination on 8/26/2021 (Pfizer) and was presented to the hospital on 9/8/2021 with persistently high fevers and altered mental status and given broad spectrum antibiotics without being able to localize the source of infection. Lumbar puncture was normal and a bone marrow biopsy was reviewed with the hematology department who diagnosed the patient with HLH. Patient was neutropenic when he came in with a WBC of 0.8 which recovered to 2.4 after receiving Zarxio from 9/8-9/12. 9/16 Patient was treated with IVIG (60g/day) x 3 days, methylprednisolone 3 mg/kg x 3 days, then 2 mg/kg x 3 days, then 1 mg/kg for 4 days. Remains on vasopressors including norepinephrine, vasopressin, and phenylephrine and is being treated with meropenem with no localized source of infection. Patient is currently intubated.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lymphocytic infiltration, Marrow hyperplasia, Megakaryocytes normal, Monocyte percentage, Musculoskeletal chest pain
Clinical narrative: 64 year old patient with history of ASH/NASH cirrhosis c/b encephalopathy, ascites (multiple LVPs in past), edema and esophageal varices (no bleeds) who had an umbilical hernia repair in 8/2020, CKD (stage 3), who underwent liver transplant on 5/12/2021. Patient reported fatigue and malaise since the COVID vaccination on 8/26/2021 (Pfizer) and was presented to the hospital on 9/8/2021 with persistently high fevers and altered mental status and given broad spectrum antibiotics without being able to localize the source of infection. Lumbar puncture was normal and a bone marrow biopsy was reviewed with the hematology department who diagnosed the patient with HLH. Patient was neutropenic when he came in with a WBC of 0.8 which recovered to 2.4 after receiving Zarxio from 9/8-9/12. 9/16 Patient was treated with IVIG (60g/day) x 3 days, methylprednisolone 3 mg/kg x 3 days, then 2 mg/kg x 3 days, then 1 mg/kg for 4 days. Remains on vasopressors including norepinephrine, vasopressin, and phenylephrine and is being treated with meropenem with no localized source of infection. Patient is currently intubated.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Natural killer cell count, Pancytopenia, Parasite blood test, Parvovirus B19 test negative, Pyrexia
Clinical narrative: 64 year old patient with history of ASH/NASH cirrhosis c/b encephalopathy, ascites (multiple LVPs in past), edema and esophageal varices (no bleeds) who had an umbilical hernia repair in 8/2020, CKD (stage 3), who underwent liver transplant on 5/12/2021. Patient reported fatigue and malaise since the COVID vaccination on 8/26/2021 (Pfizer) and was presented to the hospital on 9/8/2021 with persistently high fevers and altered mental status and given broad spectrum antibiotics without being able to localize the source of infection. Lumbar puncture was normal and a bone marrow biopsy was reviewed with the hematology department who diagnosed the patient with HLH. Patient was neutropenic when he came in with a WBC of 0.8 which recovered to 2.4 after receiving Zarxio from 9/8-9/12. 9/16 Patient was treated with IVIG (60g/day) x 3 days, methylprednisolone 3 mg/kg x 3 days, then 2 mg/kg x 3 days, then 1 mg/kg for 4 days. Remains on vasopressors including norepinephrine, vasopressin, and phenylephrine and is being treated with meropenem with no localized source of infection. Patient is currently intubated.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Respiratory viral panel, SARS-CoV-2 test negative, Serum ferritin increased, T-lymphocyte count, Traumatic haematoma
Clinical narrative: 64 year old patient with history of ASH/NASH cirrhosis c/b encephalopathy, ascites (multiple LVPs in past), edema and esophageal varices (no bleeds) who had an umbilical hernia repair in 8/2020, CKD (stage 3), who underwent liver transplant on 5/12/2021. Patient reported fatigue and malaise since the COVID vaccination on 8/26/2021 (Pfizer) and was presented to the hospital on 9/8/2021 with persistently high fevers and altered mental status and given broad spectrum antibiotics without being able to localize the source of infection. Lumbar puncture was normal and a bone marrow biopsy was reviewed with the hematology department who diagnosed the patient with HLH. Patient was neutropenic when he came in with a WBC of 0.8 which recovered to 2.4 after receiving Zarxio from 9/8-9/12. 9/16 Patient was treated with IVIG (60g/day) x 3 days, methylprednisolone 3 mg/kg x 3 days, then 2 mg/kg x 3 days, then 1 mg/kg for 4 days. Remains on vasopressors including norepinephrine, vasopressin, and phenylephrine and is being treated with meropenem with no localized source of infection. Patient is currently intubated.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Viral test
Clinical narrative: 64 year old patient with history of ASH/NASH cirrhosis c/b encephalopathy, ascites (multiple LVPs in past), edema and esophageal varices (no bleeds) who had an umbilical hernia repair in 8/2020, CKD (stage 3), who underwent liver transplant on 5/12/2021. Patient reported fatigue and malaise since the COVID vaccination on 8/26/2021 (Pfizer) and was presented to the hospital on 9/8/2021 with persistently high fevers and altered mental status and given broad spectrum antibiotics without being able to localize the source of infection. Lumbar puncture was normal and a bone marrow biopsy was reviewed with the hematology department who diagnosed the patient with HLH. Patient was neutropenic when he came in with a WBC of 0.8 which recovered to 2.4 after receiving Zarxio from 9/8-9/12. 9/16 Patient was treated with IVIG (60g/day) x 3 days, methylprednisolone 3 mg/kg x 3 days, then 2 mg/kg x 3 days, then 1 mg/kg for 4 days. Remains on vasopressors including norepinephrine, vasopressin, and phenylephrine and is being treated with meropenem with no localized source of infection. Patient is currently intubated.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Aspiration pleural cavity, Bacterial test negative, Biopsy bone marrow abnormal, Blood lactate dehydrogenase increased, CSF test normal
Clinical narrative: 64 year old patient with history of ASH/NASH cirrhosis c/b encephalopathy, ascites (multiple LVPs in past), edema and esophageal varices (no bleeds) who had an umbilical hernia repair in 8/2020, CKD (stage 3), who underwent liver transplant on 5/12/2021. Patient reported fatigue and malaise since the COVID vaccination on 8/26/2021 (Pfizer) and was presented to the hospital on 9/8/2021 with persistently high fevers and altered mental status and given broad spectrum antibiotics without being able to localize the source of infection. Lumbar puncture was normal and a bone marrow biopsy was reviewed with the hematology department who diagnosed the patient with HLH. Patient was neutropenic when he came in with a WBC of 0.8 which recovered to 2.4 after receiving Zarxio from 9/8-9/12. 9/16 Patient was treated with IVIG (60g/day) x 3 days, methylprednisolone 3 mg/kg x 3 days, then 2 mg/kg x 3 days, then 1 mg/kg for 4 days. Remains on vasopressors including norepinephrine, vasopressin, and phenylephrine and is being treated with meropenem with no localized source of infection. Patient is currently intubated.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Endotracheal intubation, Fatigue, Fungal test negative, Haemophagocytic lymphohistiocytosis, Hyperferritinaemia
Clinical narrative: 64 year old patient with history of ASH/NASH cirrhosis c/b encephalopathy, ascites (multiple LVPs in past), edema and esophageal varices (no bleeds) who had an umbilical hernia repair in 8/2020, CKD (stage 3), who underwent liver transplant on 5/12/2021. Patient reported fatigue and malaise since the COVID vaccination on 8/26/2021 (Pfizer) and was presented to the hospital on 9/8/2021 with persistently high fevers and altered mental status and given broad spectrum antibiotics without being able to localize the source of infection. Lumbar puncture was normal and a bone marrow biopsy was reviewed with the hematology department who diagnosed the patient with HLH. Patient was neutropenic when he came in with a WBC of 0.8 which recovered to 2.4 after receiving Zarxio from 9/8-9/12. 9/16 Patient was treated with IVIG (60g/day) x 3 days, methylprednisolone 3 mg/kg x 3 days, then 2 mg/kg x 3 days, then 1 mg/kg for 4 days. Remains on vasopressors including norepinephrine, vasopressin, and phenylephrine and is being treated with meropenem with no localized source of infection. Patient is currently intubated.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypertriglyceridaemia, Immunoglobulin therapy, Infection, Laboratory test normal, Lumbar puncture normal
Clinical narrative: 64 year old patient with history of ASH/NASH cirrhosis c/b encephalopathy, ascites (multiple LVPs in past), edema and esophageal varices (no bleeds) who had an umbilical hernia repair in 8/2020, CKD (stage 3), who underwent liver transplant on 5/12/2021. Patient reported fatigue and malaise since the COVID vaccination on 8/26/2021 (Pfizer) and was presented to the hospital on 9/8/2021 with persistently high fevers and altered mental status and given broad spectrum antibiotics without being able to localize the source of infection. Lumbar puncture was normal and a bone marrow biopsy was reviewed with the hematology department who diagnosed the patient with HLH. Patient was neutropenic when he came in with a WBC of 0.8 which recovered to 2.4 after receiving Zarxio from 9/8-9/12. 9/16 Patient was treated with IVIG (60g/day) x 3 days, methylprednisolone 3 mg/kg x 3 days, then 2 mg/kg x 3 days, then 1 mg/kg for 4 days. Remains on vasopressors including norepinephrine, vasopressin, and phenylephrine and is being treated with meropenem with no localized source of infection. Patient is currently intubated.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Malaise, Mental status changes, Neutropenia, Pancytopenia, Pyrexia
Clinical narrative: 64 year old patient with history of ASH/NASH cirrhosis c/b encephalopathy, ascites (multiple LVPs in past), edema and esophageal varices (no bleeds) who had an umbilical hernia repair in 8/2020, CKD (stage 3), who underwent liver transplant on 5/12/2021. Patient reported fatigue and malaise since the COVID vaccination on 8/26/2021 (Pfizer) and was presented to the hospital on 9/8/2021 with persistently high fevers and altered mental status and given broad spectrum antibiotics without being able to localize the source of infection. Lumbar puncture was normal and a bone marrow biopsy was reviewed with the hematology department who diagnosed the patient with HLH. Patient was neutropenic when he came in with a WBC of 0.8 which recovered to 2.4 after receiving Zarxio from 9/8-9/12. 9/16 Patient was treated with IVIG (60g/day) x 3 days, methylprednisolone 3 mg/kg x 3 days, then 2 mg/kg x 3 days, then 1 mg/kg for 4 days. Remains on vasopressors including norepinephrine, vasopressin, and phenylephrine and is being treated with meropenem with no localized source of infection. Patient is currently intubated.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Serum ferritin increased, Splenomegaly, Viral test negative, White blood cell count decreased
Clinical narrative: 64 year old patient with history of ASH/NASH cirrhosis c/b encephalopathy, ascites (multiple LVPs in past), edema and esophageal varices (no bleeds) who had an umbilical hernia repair in 8/2020, CKD (stage 3), who underwent liver transplant on 5/12/2021. Patient reported fatigue and malaise since the COVID vaccination on 8/26/2021 (Pfizer) and was presented to the hospital on 9/8/2021 with persistently high fevers and altered mental status and given broad spectrum antibiotics without being able to localize the source of infection. Lumbar puncture was normal and a bone marrow biopsy was reviewed with the hematology department who diagnosed the patient with HLH. Patient was neutropenic when he came in with a WBC of 0.8 which recovered to 2.4 after receiving Zarxio from 9/8-9/12. 9/16 Patient was treated with IVIG (60g/day) x 3 days, methylprednisolone 3 mg/kg x 3 days, then 2 mg/kg x 3 days, then 1 mg/kg for 4 days. Remains on vasopressors including norepinephrine, vasopressin, and phenylephrine and is being treated with meropenem with no localized source of infection. Patient is currently intubated.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Intermenstrual bleeding
Clinical narrative: Vaginal bleeding beginning 4 days post-vaccination. She is 54 years old, says she is menopausal and that her last period was approximately November or December 2020. Bleeding has not stopped and has been consistent since it began, saturating 1-2 pads/day. No other adverse effects reported. She went to the emergency department yesterday and is now scheduled to see a gynecologist on 10/1/2021.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heavy menstrual bleeding, Postmenopausal haemorrhage
Clinical narrative: Vaginal bleeding beginning 4 days post-vaccination. She is 54 years old, says she is menopausal and that her last period was approximately November or December 2020. Bleeding has not stopped and has been consistent since it began, saturating 1-2 pads/day. No other adverse effects reported. She went to the emergency department yesterday and is now scheduled to see a gynecologist on 10/1/2021.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Feeling abnormal, Fibrin D dimer, Full blood count
Clinical narrative: D1 severe headache, palpitations, achy joint/muscles, fatigue D2 Headache, achy joint/muscle fatigue D3 mild headache, brain fog, tingle/itching face (lips), fatigue, started menstural cycle 4 days early and heavy bleeding D4 - present: mild constant headaches, brain fog, tingling legs and  lips, fatigue
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heavy menstrual bleeding, International normalised ratio, Menstrual disorder, Myalgia
Clinical narrative: D1 severe headache, palpitations, achy joint/muscles, fatigue D2 Headache, achy joint/muscle fatigue D3 mild headache, brain fog, tingle/itching face (lips), fatigue, started menstural cycle 4 days early and heavy bleeding D4 - present: mild constant headaches, brain fog, tingling legs and  lips, fatigue
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Paraesthesia, Paraesthesia oral, Pruritus
Clinical narrative: D1 severe headache, palpitations, achy joint/muscles, fatigue D2 Headache, achy joint/muscle fatigue D3 mild headache, brain fog, tingle/itching face (lips), fatigue, started menstural cycle 4 days early and heavy bleeding D4 - present: mild constant headaches, brain fog, tingling legs and  lips, fatigue
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fear, Panic attack, Sleep disorder, Swollen tongue
Clinical narrative: Panic attack induced by throat, soft pallet, tongue swelling causing shortness of breath and inability to sleep due to fear. Did take aspirin and ibuprofen to attempt to reduce swelling and monitored for approximately 12 hours before feeling relief
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Breast feeding, Injection site pain, Maternal exposure during breast feeding, Sick relative
Clinical narrative: The only affect on myself was soreness in my left arm at the injection site for several weeks following the vaccine. My son is 2 years old and still nursing a few times a day. He has sever and persistent vomiting followed by an intermittent low grade fever for several days . While having the fevers occurred his entire body was covered in a rash. The rash was tiny red bumps that didn?t seem to itch and went way almost completely during the times the fever went away.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Autoimmune disorder, Condition aggravated, Impaired work ability, Inflammation, Injection site pain
Clinical narrative: On the 6th day after the first vaccine my auto immune issues flared up. I have not flared up for three years. I had extreme inflammation and pain in my wrists, fingers, right knee, back and sides, and left injection shoulder. I also had swelling in the lymph nodes in my gums and throat. This lasted a week and I called in sick and could not do my day to day things. I did not seek hospital help.  I am still not 100% but am feeling better. The reason for putting this in is because I want it documented and our vaccine injury site states you can only file a injury if it happens within 3 days of vaccine.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities, Lymphadenopathy, Pain
Clinical narrative: On the 6th day after the first vaccine my auto immune issues flared up. I have not flared up for three years. I had extreme inflammation and pain in my wrists, fingers, right knee, back and sides, and left injection shoulder. I also had swelling in the lymph nodes in my gums and throat. This lasted a week and I called in sick and could not do my day to day things. I did not seek hospital help.  I am still not 100% but am feeling better. The reason for putting this in is because I want it documented and our vaccine injury site states you can only file a injury if it happens within 3 days of vaccine.
Age: 64.0
Sex: F
Vaccine: FLUR4
Symptoms: Discomfort, Injection site erythema, Injection site inflammation, Injection site pruritus, Injection site swelling
Clinical narrative: Within 15 minutes of vaccine the injection site started to itch and swell. Within 60  minutes the back of my throat started to itch, the injection site was hot, red, swelling area 3" x 3" with a raised margin of 0.25 inches on 2 sides.  I went swimming (swam gently) in the Sound as it was cool salt water.  My arm continued to become inflamed (red, hot, swollen, itchy) spreading to my shoulder and down to my elbow.  I took a Benadryl before bed.  I spoke with the pharmacist at 4 pm the next day who suggested taking ibuprofen to reduce the inflammation.  I could not continue to take the Benadryl during the day since I had to drive.  I took one again at night along with the Ibuprofen.  I also iced my arm every night.  in 24 hours my arm was hurting with the heat and pressure.  It felt like it was inflamed to the bone.  The inflammation was wrapped around all but 2 inches under my arm.  By Friday am it was not hot nor as red.  It remained itchy until Monday.  I used a topical hydrocortisone.  As of today, 9.22 the itchy feeling has mostly subsided.
Age: 64.0
Sex: F
Vaccine: FLUR4
Symptoms: Injection site warmth, Pain in extremity, Skin warm, Throat irritation
Clinical narrative: Within 15 minutes of vaccine the injection site started to itch and swell. Within 60  minutes the back of my throat started to itch, the injection site was hot, red, swelling area 3" x 3" with a raised margin of 0.25 inches on 2 sides.  I went swimming (swam gently) in the Sound as it was cool salt water.  My arm continued to become inflamed (red, hot, swollen, itchy) spreading to my shoulder and down to my elbow.  I took a Benadryl before bed.  I spoke with the pharmacist at 4 pm the next day who suggested taking ibuprofen to reduce the inflammation.  I could not continue to take the Benadryl during the day since I had to drive.  I took one again at night along with the Ibuprofen.  I also iced my arm every night.  in 24 hours my arm was hurting with the heat and pressure.  It felt like it was inflamed to the bone.  The inflammation was wrapped around all but 2 inches under my arm.  By Friday am it was not hot nor as red.  It remained itchy until Monday.  I used a topical hydrocortisone.  As of today, 9.22 the itchy feeling has mostly subsided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Mucosal inflammation, Oral herpes, Paraesthesia, Skin burning sensation
Clinical narrative: Skin burning and prickly all mucus  membrane  areas are  burning and painful feels like my cold sore is coming to life.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Cardiac flutter, Disturbance in attention, Dyspnoea, Dyspnoea exertional
Clinical narrative: Heart palpitations intermittently starting about 3rd day after vaccine dose.   Continuing through now, evening of 9-22-2021.   No chest pain, but uncomfortable feeling of heart flutter and and pressure in head.   Sometimes lasts for one or two hours.   Slight sensation of having to concentrate harder to do a task, and body feeling "nervous".   Tend to feel slightly breathless after moving around. At time of vaccine dose on 9-13 no problems.  Day after only slightly sore shoulder, which faded in a day or so.   Thought I was doing better than most people with body's response to mRNA vaccine....until fluttery chest around 9-16.   Slightly sore shoulder returned a week later on 9-20, at which time the fluttery heart feeling became more persistent and often.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Head discomfort, Nervousness, Palpitations
Clinical narrative: Heart palpitations intermittently starting about 3rd day after vaccine dose.   Continuing through now, evening of 9-22-2021.   No chest pain, but uncomfortable feeling of heart flutter and and pressure in head.   Sometimes lasts for one or two hours.   Slight sensation of having to concentrate harder to do a task, and body feeling "nervous".   Tend to feel slightly breathless after moving around. At time of vaccine dose on 9-13 no problems.  Day after only slightly sore shoulder, which faded in a day or so.   Thought I was doing better than most people with body's response to mRNA vaccine....until fluttery chest around 9-16.   Slightly sore shoulder returned a week later on 9-20, at which time the fluttery heart feeling became more persistent and often.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site vesicles
Clinical narrative: Inches away from injection site I developed a yellow bubbly blister.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Nausea, Urticaria, Vomiting
Clinical narrative: hives, short of breath, nausea, vomiting, headache- given epinephrine , Benadryl, solumedrol, iv fluids
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue, Headache, Oropharyngeal pain, Pyrexia
Clinical narrative: Sore throat, headache, light cough, fatigue, fever
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Tingling in mid back and legs. Now tingling mid right back off and on
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Insomnia, Lethargy, Logorrhoea
Clinical narrative: Approximately 7 hours after IM injection I developed chills, quaking tremors, and a fever of 99.8. I had extremely painful muscle aches as well as a very bad headache which has continued on and off until currently. The severity has lessened. I was hyper-verbal for about six hours and found it very difficult to sleep. I continue to experience lethargy and malaise.   This is only one week out so I do not know if there will be other issues.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Pyrexia, Tremor
Clinical narrative: Approximately 7 hours after IM injection I developed chills, quaking tremors, and a fever of 99.8. I had extremely painful muscle aches as well as a very bad headache which has continued on and off until currently. The severity has lessened. I was hyper-verbal for about six hours and found it very difficult to sleep. I continue to experience lethargy and malaise.   This is only one week out so I do not know if there will be other issues.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Cellulitis, Rash, Vaccination site induration, Vaccination site swelling
Clinical narrative: The patient developed a rash and the vaccination site was swollen and hard. She was diagnosed w/ cellulitis at the ER and  got a prescription for Cephalexin and as of 9/22/21 should have started on the antibiotics. We are still waiting to see if there is any improvements.